A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 Monotherapy in Subjects with Advanced Solid Tumors

  • Parakh, Sagun (Primary Chief Investigator (PCI))
  • Day, Daphne (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date24/09/19 → 23/09/24

Keywords

  • phase 1 study
  • clinical trial
  • treatment efficacy
  • solid tumour